The adverse events of influenza A (H1N1) vaccination and its risk factors in healthcare personnel in 18 military healthcare units in Korea

Japanese Journal of Infectious Diseases

Volumn 64, Issue 3, 2011, Pages 183-189

  Hwang, Se Min ^a   Choe, Kang Won ^b   Cho, Sang Heon ^c   Yoon, Seok Jun ^d   Park, Dong Ean ^a   Kang, Jum Sook ^a   Kim, Min Jeong ^d   Chun, Byung Chul ^d,e   Lee, Sang Min ^b  

^a Armed Forces Medical Command ^*  (South Korea)

^b Armed Forces Capital Hospital   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Korea University   (South Korea)

^e Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; ALCOHOL CONSUMPTION; ANXIETY; ARTHRALGIA; ARTICLE; BODY RASH; CARDIOVASCULAR DISEASE; CHILL; COMORBIDITY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DEPRESSION; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DYSPEPSIA; DYSPNEA; FATIGUE; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; GENDER; GUILLAIN BARRE SYNDROME; HEADACHE; HEALTH CARE PERSONNEL; HEART PALPITATION; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INJECTION SITE EDEMA; INJECTION SITE PAIN; INJECTION SITE PRURITUS; INJECTION SITE RASH; INJECTION SITE REACTION; INJECTION SITE VESICLE; INJECTION SITE WARMTH; KOREA; MALE; MILITARY NURSE; MILITARY PHYSICIAN; MYALGIA; NAUSEA; NERVOUSNESS; NEUROLOGIC DISEASE; NOSE OBSTRUCTION; OBESITY; OCCUPATIONAL HEALTH; OPTIC NEURITIS; PNEUMONIA; POSTNASAL DRIP; PREGNANCY; RESPIRATORY TRACT DISEASE; RHINORRHEA; RISK FACTOR; SIDE EFFECT; SKIN DISEASE; SMOKING; SNEEZING; SOMNOLENCE; SPONTANEOUS ABORTION; SPUTUM; SUDDEN DEATH; SYSTEMIC DISEASE; THORAX PAIN; TINNITUS; UNCONSCIOUSNESS; URTICARIA; VACCINATION REACTION; VISUAL ACUITY; VOMITING; WEAKNESS; WHEEZING;

ADULT; FATIGUE; FEMALE; FEVER; HEALTH PERSONNEL; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MILITARY PERSONNEL; PAIN; PREGNANCY; QUESTIONNAIRES; REPUBLIC OF KOREA; RISK FACTORS; VACCINATION; YOUNG ADULT;

EID: 79958036399     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Swedish, K.A., Conenello, G. and Factor, S.H. (2010): First Season of 2009 H1N1 Influenza. Mt. Sinai. J. Med., 77, 103-113.
2. Poland, G.A., Tosh, P. and Jacobson, R.M. (2005): Requiring influenza vaccination for health care workers: seven truths we must accept. Vaccine, 23, 2251-2255.
3. Arguedas, A., Soley, C. and Lindert, K. (2009): Responses to 2009 H1N1 vaccine in children 3 to 17 years of age. N. Engl. J. Med., 362, 370-372.
4. Nolan, T., McVernon, J., Skeljo, M., et al. (2010): Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in infants and children: a randomized trial. JAMA, 303, 37-46.
5. Greenberg, M.E., Lai, M.H., Hartel, G.F., et al. (2009): Response to a monovalent 2009 influenza A (H1N1) vaccine. N. Engl. J. Med., 361, 2405-2413.
6. Zhu, F.C., Wang, H., Fang, H.H., et al. (2009): A novel influenza A (H1N1) vaccine in various age groups. N. Engl. J. Med., 361, 2414-2423.
7. Roman, F., Vaman, T., Gerlach, B., et al. (2009): Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial. Vaccine, 28, 1740-1745.
8. Clark, T.W., Pareek, M., Hoschler, K., et al. (2009): Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N. Engl. J. Med., 361, 2424-2435.
9. Liang, X.F., Wang, H.Q., Wang, J.Z., et al. (2010): Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet, 375, 56-66.
10. Plennevaux, E., Sheldon, E., Blatter, M., et al. (2010): Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. Lancet, 375, 41-48.
11. Nichol, K.L. and Hauge, M. (1997): Influenza vaccination of healthcare workers. Infect. Control Hosp. Epidemiol., 18, 189-194.
12. Hampton, T. (2009): H1N1 vaccine urged for health workers, but some resist getting on board. JAMA, 302, 1848-1849.
13. Santibanez, S., Fiore, A.E., Merlin, T.L., et al. (2009): A primer on strategies for prevention and control of seasonal and pandemic influenza. Am. J. Public Health, 99 (Suppl. 2), S216-S224.
14. Naz, H., Cevik, F. and Aykin, N. (2009): Influenza vaccination in healthcare workers. J. Infect. Dev. Ctries., 3, 50-54.
15. Carman, W.F., Elder, A.G., Wallace, L.A., et al. (2000): Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet, 355, 93-97.
16. Potter, J., Stott, D.J., Roberts, M.A., et al. (1997): Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J. Infect. Dis., 175, 1-6.
17. Saxen, H. and Virtanen, M. (1999): Randomized, placebo-controlled double blind study on the efficacy of influenza immunization on absenteeism of health care workers. Pediatr. Infect. Dis. J., 18, 779-783.
18. Wilde, J.A., McMillan, J.A., Serwit, J., et al. (1999): Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA, 281, 908-913.
19. Centers for Disease Control and Prevention (2000): Updated recommendations from the Advisory Committee on Immunization Practices in response to delays in supply of influenza vaccine for the 2000-01 season. JAMA, 284, 2050-2052.
20. Pfeifer, D., Alfonso, C. and Wood, D. (2010): Defining the safety profile of pandemic influenza vaccines. Lancet, 375, 9-11.
21. Greene, S.K., Kulldorff, M., Lewis, E.M., et al. (2010): Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. Am. J. Epidemiol., 171, 177-188.
22. Black, S., Eskola, J., Siegrist, C.A., et al. (2009): Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet, 374, 2115-2122.
23. Vajo, Z., Tamas, F., Sinka, L., et al. (2010): Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomized controlled trial. Lancet, 375, 49-55.
24. Vajo, Z., Wood, J., Kosa, L., et al. (2010): A single-dose influenza A (H5N1) vaccine safe and immunogenic in adult and elderly patients: an approach to pandemic vaccine development. J. Virol., 84, 1237-1242.
25. Rodrigues, L.C. and Smith, P.G. (1999): Use of the case-control approach in vaccine evaluation: efficacy and adverse effects. Epidemiol. Rev., 21, 56-72.
26. Destefano, F. and Tokars, J. (2010): H1N1 vaccine safety monitoring: beyond background rates. Lancet, 375, 1146-1147.
27. Caplan, A.L. (2010): Unlicensed pandemic influenza A H1N1 vaccines. Lancet, 375, 444-445.